Brilinta Tablets and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Brilinta Tablets and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ticagrelor
Brand name: Brilinta
Synonyms: Brilinta
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brilinta Tablets-Insulin glargine, recombinant Subcutaneous
- Brilinta Tablets-Insulin glulisine
- Brilinta Tablets-Insulin Glulisine (Cartridges and Pens)
- Brilinta Tablets-Insulin Glulisine (Vials)
- Brilinta Tablets-Insulin glulisine Subcutaneous
- Brilinta Tablets-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine and brinzolamide ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine and Timolol
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine and timolol ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine Tartrate eent